Medical Marijuana, Inc. appointed Dr. Timothy R. Scott as its new Chief Executive Officer. Dr. Scott takes the helm of the organization after serving on the Company's board since 2015, as well as for several years on the Boards of both of the entities that comprise the Company's investment holdings, signaling a thorough understanding of the Company's operating subsidiaries and portfolio investments. Dr. Scott had recently taken an advisory role within the Company, having accepted a position as the Chief People Officer, before accepting this new role of CEO.

Dr. Scott's appointment follows the acceptance by the Board of Directors of the resignation of Blake N. Schroeder who served as the Company's CEO, President and Chairman of the Board since 2021 and served in other executive roles going back to 2016. Mr. Schroeder will continue to serve on the boards of the Company's portfolio investments; Axim Biotechnologies, Inc. and Neuropathix, Inc. In addition, he will provide consulting and advisory services to Neuropathix.